Abstract
In view of the exponential rise of global obesity in the past three quarters of the century, it is useful to examine what is driving this change and what approaches can curb it. The chief drivers of weight gain are, on one hand our misunderstanding of the mechanisms controlling energy balance, and, on the other, reliance on current, potentially misleading conflicting scientific opinions and government policies regarding the controls of human appetite. This review outlines the evidence that: (1) there is no direct bioenergetic feedback from energy metabolism or energy stores to the brain mechanisms guiding feeding and energy expenditure, (2) human appetite is controlled by signals originating from an empty or full stomach, food palatability and opportunities to eat as well by the rate of food absorption, that (3) humans bear a genetic burden of having high ability and capacity to store fat and mechanisms that curb body- mass and fat loss, (4) humans are motivated to overconsume while maintaining low energy expenditure, and (5) commercial interests of food businesses marketing highly palatable foods, and wide-spread mechanization of living tasks and urban design reduce the need for physical work and movement. The non-pharmacological and non-surgical solutions to obesity involve an understanding of human genetic impediments and environmental obstacles to maintaining healthy weight, coupled with deliberate corrective or preventive behaviors, such as understanding and using gastrointestinal tract signals that provide sufficient, albeit subtle, cues for sensible food intake, and using daily weight monitoring and activity tracking devices to record and motivate healthy levels of physical activity.
INTRODUCTION
The exponential rise of excess weight and obesity in the past three quarters of a century poses a global health problem1. Prevalence of obesity in 200 countries world-wide tripled between 1975 and 2014 and continues to rise2,3. In the USA, 65% adults were overweight, and 42% were obese in 20184. Being overweight or obese risks developing a cluster of cardiovascular (CVD) and metabolic diseases5,6. Because of the difficulty of reducing excess weight long-term by lifestyle approaches7,8, obesity has been characterized as a chronic, relapsable disease by American Medical Association in 2013 and by European Health Commission in 20219.
This review provides evidence that individuals have the agency to prevent and reduce obesity by paying attention to the gastrointestinal (GI) signals as the principal guides to human appetite and energy balance and by being cognizant of human physiological limitations and environmental obstacles to maintaining healthy weight. The endogenous mechanisms for elicitation of hunger and satiation are outlined first. Human physiological limitations, such as large inborn capacity to store fat and enlarge stomach size, social and environmental factors leading to overeating, reasons for inadequate motivation to expend energy, and multiple defenses against body fat loss, are discussed next. Finally, suggestions are provided for successful use of hunger and fullness signals and for avoidance of environmental interference, while deliberately controlling meal taking and enjoying exercise energy expenditure.
EVIDENCE-BASED THESIS
1. Endogenous elicitation of hunger.
Our sensation of hunger is an inborn signal and key motivator to seek food and initiate eating. While eating is accompanied by the release of several digestive and absorptive hormones, some of which may contribute to any sensation of satiation, no obvious trigger for hunger was initially recognized. Then, in 2001, a gastric hormone ghrelin, a GH secretagogue, was found to be secreted synchronously with the initiation and termination of meals10. Neither this first report, nor the follow-up paper11 showing a 24% increase in meal-associated ghrelin concentrations after weight loss in subjects with obesity, and the hormone’s disappearance after gastric surgery, actually measured the appetite ratings. Yet, its general acceptance as a stimulus of hunger was a result of a report12 that infusions of ghrelin at 5 pM/kg/h resulting in supra-physiological plasma ghrelin concentrations, increased food intake and raised hunger scores at meal times12. Several questions related to acceptance of ghrelin as a cause of hunger remain. At the infusion rate 5 pM/kg/h and its supra-physiological concentrations, ghrelin elicited near maximal GH secretion12. Another GH secretagogue, GHRP-2, stimulated a 36% increase in food intake13, but this did not challenge the conclusion that ghrelin, rather than GH, stimulated hunger. Ghrelin may also affect hunger by participating in glucoregulation, energy homeostasis, cardioprotection, muscle atrophy, and bone metabolism14.
Long forgotten was a classical 1912 study15 which demonstrated a close relationship between stomach contractions and reports of stomach hunger pangs. Dr. Washburn reported these in fasting state, as his stomach was equipped with a water-filled balloon and connected to a recorder which demonstrated to the attending Dr. Cannon a correspondence between the graphed stomach contractions and reported hunger pangs (Figure 1). Most well-nourished individuals will seldom reach a level of fasting sufficient to detect clear hunger pangs, but almost all of us are aware of an empty stomach after our meals have been digested.
Figure 1:

One half the original size. The top record represents intragastric pressure (the small oscillations due to respiration, the large to contractions of the stomach); the second record is time in minutes (ten minutes); the third record is W’s report of hunger pangs; the lowest record is respiration registered by means of a pneumograph about the abdomen.
2. Endogenous perception of satiation or fullness.
Gastric wall stretch and tension trigger afferent mechanoreceptor and vagal signals to the brain that produce a sensation of fullness in proportion to the volume of the ingested meal16. Sensation of fullness upon eating, and associated autonomic and hormonal messages to the brain, reduce and stop food intake as an immediate meal-associated negative feedback17. A number of studies attest to the dominant role of meal size and stomach stretch in the sensation of fullness. In an 11-week study18, healthy volunteers consumed identical meals differing only in energy density, containing either 30 to 35% fat, or 20 to 25% fat. Both groups consumed approximately the same daily volume of food (between 1400 and 1450 g) without adjusting the quantity eaten to the difference in dietary energy content. As a result, the body weights of the two groups diverged.
In studies employing different-size intragastric nutrient loads, satiation increased in proportion to the load volume and stomach stretch19. In the third line of research20, hunger was measured in response to meals of different size (100 vs 500 kcal) taken by mouth and to intravenous total parenteral (TPN) supplementation of small meals with missing calories. Hunger was also tested when the large meal was combined with exercise-induced energy expenditure that depleted almost all of ingested calories in the large meal, with or without intravenous supplementation. Only the size of meals, ingested by mouth and processed by the GI tract, influenced hunger and satiation (Figure 2). The 100 kcal meal elicited higher hunger and lower fullness than the 500 kcal meal. Supplementation of energy withheld from small meals or reduced by exercise, by intravenous nutrients did not influence either hunger or satiation. The dependence of hunger and sensation of fullness on the volume of food eaten by mouth and the GI transit of food is core evidence that oral and GI volumetric signals are the principal guides to human appetite.
Figure 2.

Hunger (left) and fullness (right) are detected only when orally eaten food is processed by the GI tract. Both sensations respond to the volume of the meal (open circles: SED-AL 500 Kcal, SED-R 100 kcal meal). Intravenously supplemented calories in the small meal (SED-R-TPN, solid circle, left panel) or calories expended by exercise (open rectangles) (TPN, solid rectangles, right panel) were not detected. Modified from Borer et al., 2009.
3. Gut peptides primarily facilitate digestion and may incidentally control appetite.
Four gut peptides are considered to directly contribute either to hunger (ghrelin) or satiation (cholecystokinin, CCK, glucagon-like peptide 1, GLP-1, and peptide YY, PYY) in addition to controlling digestion by affecting GI physiology. Elicitation of hunger attributed to ghrelin was previously described. CCK arises from the duodenum, the proximal part of the small intestine, to stimulate gall bladder contractions and bile secretion for emulsification of dietary fat. It also affects pancreatic secretion and slows down gastric emptying. lntraperitoneal administration of CCK to sham-fed hungry rats21 stopped their feeding, and triggered a sensation of fullness in hungry humans after intragastric CCK infusion in combination with stomach-distending water balloons. Gall-bladder cramps were reported at higher concentrations22. Glucose-dependent insulinotropic peptide (GIP) and GLP-1 are incretins, hormones that enhance insulin secretion to glucose above what is seen with glucose ingestion alone23,24. GIP is secreted from upper, and GLP-1 from L cells in distal, small intestine. GIP also promotes energy storage in adipose tissue and osteoblast proliferation in bones. Like CCK, GLP-1 slows gastric emptying, but also suppresses glucose-dependent glucagon secretion. GLP-1 partners with peptide YY (PYY) to act as an ileal brake24,25. Both hormones are released from the enteroendocrine L cells in the distal gut responding to fat and to unabsorbed nutrients that reach ileum and colon. They change the peristaltic intestinal motility from propagative to segmenting and, by slowing GI nutrient transit, they allow proper nutrient absorption of large meals in the small intestine. Both hormones are also rapidly inactivated by the enzyme dipeptidyl peptidase IV (DPPIV). While the analogs of GLP-1 and PYY and the DPPIV inhibitors are utilized in medicine to suppress hunger and induce weight loss, the unresolved question is whether they cause satiation directly and independently of their effects on GI physiology.
To answer that question, the direct role of the five gut peptides in the control of human appetite was tested in a study26 where the secretion of ghrelin, GIP, GLP-1, PYY, and CCK were studied along with the meal-associated appetite ratings in response to energy-expending moderate-intensity exercise while fasted or during the meal-associated postprandial period. Subjects ate 1,600-kcals in two meals, at 10 and 17 h, and engaged in two hours of exercise starting either 1 h after (MX), or ending 1 h before eating (XM). We hypothesized that exercising fasted will elicit greater release of FFAs, ketone body beta-hydroxy butyrate (BHB), suppress GIP, GLP-1, PYY, CCK release and stimulate ghrelin and hunger compared to exercising after the meal. Exercising after the meal was hypothesized to elicit greater sensation of fullness and secretion of GIP, GLP-1, PYY, CCK, leptin and insulin, and lower secretion of ghrelin than exercising hungry. While differential timing of exercise with respect to meals produced expected changes in the circulating metabolic fuels, it did not substantially change the pattern of hunger and fullness as shown in Figure 3.
Figure 3.

The course of hunger (left) and fullness (right) followed the timing of the meal transit through the GI tract and was largely unaffected by the timing of exercise with respect to meals. Modified after Borer et al., 2021.
The anticipated increases in hunger and plasma ghrelin when exercise preceded the meals (XM), and of GLP-1, PYY, and CCK when exercise was performed after eating (MX), did not take place. Ghrelin, GIP, GLP-1, PYY, and CCK concentrations followed the temporal pattern of meal digestion and absorption and were largely unaffected by the timing of meals and exercise. Only leptin concentration increased with ad libitum meals and was suppressed by energy expenditure of exercise. (Figure 4). In contrast to the five gut peptides, insulin and leptin track circulating calories20 (Figure 5), but also do not affect the appetite (Figure 2). Plasma insulin and leptin concentrations changed in proportion to the intravenous nutrient load, whether it was provided by different size of eaten meal, intravenously infused nutrients, or reduced by exercise energy expenditure (Figure 5)..
Figure 4.

Concentrations of GIP, GLP-1, PYY (top panels) and ghrelin, and CCK (bottom panels) all increased during, and were timed by, digestion of the meals while being unaffected by timing of exercise with respect to meals. Only leptin concentrations responded to acute energy changes. MX= exercise after the meals, XM=Exercise before the meals, SED=sedentary controls. Modified from Borer et al., 2021
Figure 5.

Left: Insulin (upper panels) and leptin respond (lower panels) to the energy content of the meals (500 kcal in SED-AL, solid triangles, 100 kcal small meals in SED-R, open circles) eaten by mouth and digested by GI tract, and 366 Kcals of intravenous TPN infusion (SED-R-TPN). Right: Both hormones responded to expenditure of 554 kcal exercising (EX, open rectangles) in addition to calories in the meals and TPN infusion. Modified from Borer et al., 2009.
These studies20,26 support the primacy of the digestive role for GIP, GLP-1, PYY, ghrelin, and CCK in the course of the meal transit through the GI tract rather than a direct and independent effect on the appetite. Any contribution of gut peptides to fullness is incidental and most likely secondary to their effect on GI physiology.
4. Causes of human overeating.
Two powerful endogenous causes that facilitate overeating are our inborn motivation to seek palatable taste and social facilitation, a behavior to eat more in the company of conspecifics whether they are humans27, dogs28, or newly hatched chicks29. Human hedonic motivation for sweet and savory foods is evident at birth as newborn babies smile to a sweet stimulus in their mouth, and cringe to acid and bitter tastes30 (Figure 5). The reason we seek any edible food when we are food deprived, and desire food that tastes and smells good at other times, is a brain mechanism that powers both kinds of motivation, “wanting” food when our stomachs are empty, and seeking food that we “like” even when we may be well fed31. Substantial orbitofrontal, insular cortical, and limbic circuits represent a substrate of the hunger motivation in response to negative energy balance. Interspersed within this circuitry, and centered in the mesolimbic nucleus accumbens, are neural substrates of hedonic motivation (Figure 6) which operate with dopamine and opioid neurotransmitters even under energy repletion.
Figure 6.

Hedonic “liking” reactions in human babies, primates, and rats (left) and a regions of rat nucleus accumbens that control hunger or “wanting” motivation and hedonic “liking” motivation. From Berridge 2009.
We demonstrate our inborn liking of sweets by supporting development and marketing of sweet foods by food industry. Examples are doughnut shops, cake bakeries, and companies like Hershey Co, Mars Wrigley Confectionery, Nestle SA and many others. Beyond the motivation for palatability, food variety can enhance appeal and intake of food by as much as 29%32. Humans practice gastronomy and demonstrate the desire for palatability in what they cook and how they sequence palatable foods in their meals from salty and savory at the start of meals to palatable sweets at the end.
Social facilitation also leads to overeating in the company of others. The priming stimuli can include seeing other customers eating in restaurants33 or on television34, both of which can even influence the speed of eating35. It is likely that human opportunism, rather than an inborn trait, prompts people to eat more when offered a greater quantity of food at a lower price as in smorgasbord, fast-food and other restaurants33,36, 37. Overeating also is encouraged when food is offered in oversize packages38.
Environmental and social incentives to overeat are present in extended periods of wakefulness in the current artificially illuminated world. Studies on the number of daily eating episodes (defined as ingestion of greater than 5 calories at a time), show that humans eat frequently and chaotically for up to 15 hours a day whether they are slightly overweight39, or overweight and obese40. Overabundance of fast-food and convenience food stores in most countries encourages easy access to palatable nutrients and influences preponderance of obesity41,42. In addition, competitive feeding contests such as a well-known “Hot-dog” or ‘Chicken-eating’’ contests encourage ingestion of supra-physiological amounts of food43.
A final unintended social incentive to overeat was promoted by Departments of Agriculture and Health and Human Services in 2010 with a recommendation, which has not been rescinded, that Americans consume between 45 and 65% of carbohydrates in their diets44. The recommendation was strongly influenced by the research of Ancel Keys in the 1950s with the objective to prevent development of atherosclerosis and CHD from high-fat diets45. The national recommendation probably facilitated weight gain by causing a 30.5% increase in daily carbohydrate consumption from 213 g per day in 1965 to 278 g per day or 51% of daily calories in 201146. The currently high carbohydrate consumption falls within the 45 to 65% of daily calorie range as recommended since 201044.
5. Causes of human inactivity.
Higher levels of physical activity are observed within half an hour prior to scheduled mid-day and evening meals provided at 11:30, 17:00 h, and a 20:00-h in healthy-eating subjects and in subjects with night eating disorder47(Figure 7). Short episodes of sleepiness are often reported 2 to 3 h after the large meals48 indicating a reciprocal relationships between short-term energy availability and spontaneous physical activity. Similarly, an acute increase in voluntary activity in rats anticipates restricted daily meals49 and was known since 1967.
Figure 7.

Percent of spontaneous physical activity in non-nighttime eater controls and nightime eaters during 24-h stay in the respiratory chamber. From Gluck et al., 2012.
That the relationship between momentary meal taking and spontaneous activity is not fortuitous but reflects an endogenous relationship between body energy status and the motivation to move is seen by examining the relationship between body fatness and the levels of spontaneous physical activity (Figure 8). As was the case for physical activity in relation to daily meals (Figure 7), the relationship between body fat and spontaneous physical activity is non-homeostatic, in that activity increases in normal-weight subjects and declines upon weight and fat gain50,51 (Figure 8).
Figure 8.

The inverse relationship between body fat and voluntary daily energy expenditure excluding the resting metabolic rate. Modified from Rising et al., 1994 and Schultz & Schoeller 1994.
Reasons for reduced energy expenditure in contemporary developed societies are also environmental and social, as they reflect human preference for technological aids and urban design that obviate the use of physical effort in daily living.
That the recent introduction of these conveniences has influenced physical work and body fatness is illustrated in a study of the lifestyle of an Old Order Amish community in Canada during 2004 planting season52. Unlike urban dwellers in developed societies, Amish rake leaves, milk cows by hand, hand-wash laundry and dishes, chop firewood for cooking and home heating, and grow, harvest, and can their food. Amish men averaged 10 h/week of vigorous work and 12 hours/week of walking generating over 18,000 steps /day and energy expenditure of 3100 kcal/day. Amish women cared for large families, did domestic and vigorous farm work for 3.4 h/week and 39 h/week of moderate physical work, expending 1,850 kcal/day. The incidence of obesity in their community was only 4% and of overweight 26%.
The introduction of motor transportation revealed a clear positive relationship between the frequency of its use and increases in overweight and obesity53,54. Urban planning also inadvertently encourages weight gain and reduced physical activity through single-use suburban environments that necessitate the use of automobiles55 as opposed to multiple-use urban environments that encourage walking and bicycling56.
6. Human genetic predisposition for body fat storage.
Body fat in non-human primates averages between 5 and 10% of total body mass, in healthy men between 12 and 23%, and in women between 24 and 34%57.In individuals with obesity, body fat can reach upward of 50 to 60% (Figure 8), Increased capacity to store fat is hypothesized to have co-evolved with exponential development of brain size in the genus Homo over the past two million years58. The volume of human brain is more than three times the size of the brains in non-human primates (Figure 9).
Figure 9.

Increases in brain volume size in the hominid species. From Wells, 2006. Reproduced with permission.
It is speculated that the natural selection for increased fat storage and brain size co-evolved in response to seasonal fluctuations in energy resources in terrestrial savannah once humans developed bipedal locomotion. Larger brain consumes between 20 and 25% of resting metabolic rate and is benefited by larger fat stores. Evolution of increased adiposity in the human female57 supported higher energy cost of pregnancy, lactation, and feeding of multiple children.
Obesity is also a consequence of a genetic feed-forward, rather than feedback, operation of body mass control. Predisposition to seek palatable food whenever the stomach is empty and to eat chaotically over the extended wakeful period39,40 is balanced only by a temporary sensation of post-meal fullness, and not by any mechanism that would block overeating and increase energy-expending physical activity. This point is worth emphasizing as there is a scientific bias to look for a negative feedback mechanism in most life-supporting functions, such as regulation of stable blood glucose level. A homeostatic feedback hypothesis of regulation of body weight was proposed in 200059, several years after the discovery of hormone leptin60. Subsequently, circulating leptin concentration was found to be proportional to the size of the subcutaneous fat depot61. The homeostatic negative feedback was proposed to operate between the adipose tissue volume and hypothalamic brain circuits controlling feeding and energy expenditure and mediated by circulating leptin concentrations. The feedback was hypothesized to work by suppressing hunger and increasing exercise energy expenditure in proportion to the size of subcutaneous fat depot and mediated by leptin concentrations. The reverse was supposed to take place when the volume of adipose tissue declined59. This hypothesis was not supported on several counts. First, in a large trial where obese individuals were injected with doses of leptin ranging from sub-threshold to supra-physiological levels, there was no effect on appetite or weight loss62. Second, leptin concentrations rise in both humans and animals in parallel with the rise in body fat mass, a clear demonstration that this hormone does not operate as a weight-normalizing negative-feedback signal. Third, daily fat mass changes are much too small to affect meal-to-meal hunger or levels of spontaneous physical activity.
The third endogenous mechanism obstructing body fat loss includes increases in hunger and insulin sensitivity, along with reductions in energy expenditure through lower thyroid hormone titers, reduced sympathetic activity, and increased muscle work efficiency. The defense features appear to be mediated by declines in leptin concentrations during fasting as they are abolished by leptin injections to fasted and underweight individuals63. This defense mechanism is responsible for the relapse of obesity and regain of body weight after weight loss7,8 (figure 10):
Figure 10:

Percent of starting body weight lost during daily caloric restriction (DCR) and very-low calorie diet (VLCD) that is subsequently regained. Modified from Franz et al., 2007.
In meal-to-meal eating, leptin released by the stomach64, rather than from the adipose tissue65, may modulate daytime energy intake and contribute to satiety by counter-regulating insulin secretion and action66. Individuals genetically unable to secrete leptin experience increased hunger and grow obese, but leptin administration corrects both abnormalities67. Yet, assertions that leptin “maintains the relative constancy of adipose tissue mass, thereby protecting individuals from the risks associated with being ... too obese”, persist68.
The final endogenous process that assists, rather than hinders, development of obesity is the capacity of stomach to hypertrophy in response to habitual overloading due to overeating69 (Figure 9). Measurements of stomach volume by water-filled balloons reveal that obese subjects69 and bulimic subjects70 have stomach volumes up to twice the size of normal-weight individuals (Figure 11) .
Figure 11:

Changes in gastric volume as a function of obesity (left, Geliebter 1988), overeating in bulimia (center, Geliebter et al., 1992), and caloric restriction in subjects with obesity (right, Geliebter et al.,1996).
Meal intake correlated with, and stomach emptying was inversely related, to stomach size70, suggesting that enlarged gastric capacity may potentially provide a positive feedback for overeating. Individuals who habitually compete in annual Nathan’s Hot Dog Eating Contests can over 5 years increase their maximal consumption to more than 800 g/min in 10 minutes43 demonstrating the extent of large human GI plasticity. In contrast, a 4-week period of severe food restriction to 600 kcal/day produces a 27% reduction of gastric capacity71 (Figure 11, right). An even greater reduction in food consumption through a possible GI atrophy may have occurred in a case report where a 382-day absolute fast under medical supervision produced a massive weight loss followed by almost no weight gain over a subsequent 5 year period72
How best to manage body weight and energy balance?
Since the thesis of this review is that gastro-intestinal signals are the principal guides to human appetite and energy balance, how should individuals implement this guidance?. Here is a list of suggested options:
Resist environmental pressure to overeat whether caused by social facilitation during holidays, highly palatable foods, or commercial pressure to eat oversized portions in restaurants73. Follow “hara hachi bu” policy to eat only to 80% of stomach fullness as practiced by the long-lived Japanese on the island of Okinawa74;
Avoid habitual stomach overloading by overconsumption to prevent stomach hypertrophy69,70;
Be mindful of genetic obstacles to regulating body weight and body fat by substituting daily weighings of your body mass as a dependable low-tech feedback of management of energy balance75;
Incorporate deliberate physical activity (both aerobic locomotion and weight lifting) by embracing helpful technology of wearable activity monitors. They provide external motivation to exercise by stimulating our competitive impulses through step counts, energy expenditure feedback, and through intermittent encouragement to persist doing it;
Consider adding some features of intermittent fasting and meal eating to your regular routine. Time restricted eating76 counters human opportunistic tendency to snack whenever the opportunity presents itself39,40. Alternate-day fasting77 or a total fast on one, two, or three non-consecutive days during the week allow for mid-course corrections in the weight-control journey78.
Suggested recommendations work better in prevention than in correction of excess weight, but in either situation the outcome is likely to be better than doing nothing;
Finally, to oppose inborn features of human physiology and currently absent external support, national government and health organizations would need to provide counteracting external incentives for nationwide maintenance of healthy weight.
CONCLUSIONS
Exponential rise of global obesity in the past three quarters of the century produced serious health and economic burdens. The prevailing approach to solving the obesity problem has been to consider obesity as an intractable disease amenable to pharmacological and surgical solutions, as most behavioral strategies have been unsatisfactory. The thesis of this review is (1) that these approaches are based on the faulty assumption that there is an innate energy- and weight-regulatory mechanism quantitatively controlling food intake and physical activity which malfunctions in some individuals predisposing them to inevitably become obese, but (2) that individuals have agency to prevent and attenuate obesity by understanding their inherited physiological limitations and predisposing social obstacles. They have the option to do so by avoiding social obstacles, deliberately attending to the signals from the oral and gastrointestinal tract to prevent overeating, and by using technological aids to frequently monitor their body weight and exploit the motivational features of activity monitors.
Footnotes
Conflicts of Interest Statement:
None
References:
- 1.Mendis S, Davis S, Norrving B. Organizational update: The world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke 2014:45:e206–7. doi: 10.1161/STROKEAHA.114.005446. [DOI] [PubMed] [Google Scholar]
- 2.NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries trom 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19–2 million participants. Lancet 2016; 387(10026):1377–1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Obesity and overweight fact sheet, World Health Organization www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. (Accessed December 22,2022)
- 4.Fryar C, Carroll MD, Afful J. Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960–1962 through 2017–2018; NCHS Health E-Stats; U.S. National Center for Health Statistics: Hyattsville, MD, USA, 2020. [Google Scholar]
- 5.Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol 2021; 320: C375–C391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kachur S, Lavie CJ, de Schutter A, Milani RV, Ventura HO. Obesity and cardiovascular diseases. Minerva Med 2017; 108: 212–228. [DOI] [PubMed] [Google Scholar]
- 7.Franz MJ, VanWormerr JJ, Crain AL, Boucher JL, Histon T, Caplan W, Bowman JD, Pronk NP. Weight-loss outcomes: A systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007; 107: 1755–1767. [DOI] [PubMed] [Google Scholar]
- 8.Wing RR, Espeland MA, Clark JM, Hazuda HP, Knowler WC, Pownall HJ, Unick J, Wadden T, Wagenknecht L. Association of weight-loss maintenance and weight regain on 4-year changes in CVD risk factors: The action for health in diabetes (Look AHEAD) clinical trial. Diabetes Care 2016; 39: 1345–1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Christensen S recognizing obesity as a disease. J Am Assoc Nurse Pract 2020; 32: 497–503. [DOI] [PubMed] [Google Scholar]
- 10.Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714–1719. [DOI] [PubMed] [Google Scholar]
- 11.Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JO. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N EnglJ Med 2002; 346: 1623–1630. [DOI] [PubMed] [Google Scholar]
- 12.Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992. [DOI] [PubMed] [Google Scholar]
- 13.Laferrere B, Abraham C, Russell CD, Bowers CY. Growth hormone _ releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab 2005; 90: 611–614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Pradhan G, Samson SL, Sun Y. Ghrelin: much more than a hunger hormone. Curr Opin Clin Nutr Metab Care 2013;16: 619624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Cannon WB, Washburn AL. An explanation of hunger. Am J Physiol 1912; 29: 441–454. [Google Scholar]
- 16.Marciani L, Cox EF, Pritchard SE, Major G, Hoad CL, Mellows M, Hussein MO, Costigan C, Fox M, Gowland PA, Spiller RC. Additive effects of gastric volumes and macronutrient composition on the sensation of postprandial fullness in humans. Eur J Clin N utr 2015; 69: 380–384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Berthoud H-R. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil 2008; 20 (Suppl 11): 64–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kendall A, Levitsky DA, Strupp BJ, Lissner L. Weight loss on a low-fat diet: Consequence of the imprecision of the control of food intake in humans. Am J Clin Nutr 1991; 53: 1124–1129. [DOI] [PubMed] [Google Scholar]
- 19.Rolls BJ, Roe LS. Effect of volume of liquid food infused intragastrically on satiety in women. Physiol Behav 2002; 76: 623–631. [DOI] [PubMed] [Google Scholar]
- 20.Borer KT, Wuorinen E, Ku K, Burant C. Appetite responds to changes in meal content, whereas ghrelin, leptin, and insulin track changes in energy availability. J Clin Endocrinol Metab 2009; 94: 2290–2298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gibbs J, Young RC Smith GP. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 1973; 245:323–325. [DOI] [PubMed] [Google Scholar]
- 22.Kissileff HR, Carretta JC, Geliebter A, Pi-Sunyer FX. Cholecystokinin and stomach distension combine to reduce food intake in humans. Am J Physiol Regul lntegr Comp Physiol 2003; 285: R992–R998. [DOI] [PubMed] [Google Scholar]
- 23.Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007; 132: 2131–2157. [DOI] [PubMed] [Google Scholar]
- 24.Holst JJ. The physiology of glucagon-like peptide-1. Physiol Rev 2007; 87: 1409–1439. [DOI] [PubMed] [Google Scholar]
- 25.Van Clitters GW, Lin HC. lleal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 2006; 8: 367–373. [DOI] [PubMed] [Google Scholar]
- 26.Borer KT, Lin P-J, Wuorinen E. Timing of meals and exercise affects hormonal control of glucoregulation, insulin resistance, substrate metabolism, and gastrointestinal hormones but has little effect on appetite in postmenopausal women. Nutrients 2021; 13: 4342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.De Castro JM. Social facilitation of duration and size but not rate of the spontaneous meal intake of humans. Physiol Behav 1990; 47: 1129–1135. [DOI] [PubMed] [Google Scholar]
- 28.Ross S, Ross JG. Social facilitation of feeding behavior in dogs: I. group and solitary feeding. Pedagog Semin J Genet Psychol 1949; 74: 97–108. [DOI] [PubMed] [Google Scholar]
- 29.Strobel MG, Macdonald GE. Induction of eating in newly hatched chicks. J Comp Physiol Psychol 1974; 86: 493–502. [DOI] [PubMed] [Google Scholar]
- 30.Crook C Taste perception in the newborn infant. Infant Behav Dev 1978; 1: 52–69. [Google Scholar]
- 31.Berridge KC. ‘Liking’ and ‘wanting’ food rewards: Brain substrates and roles in eating disorders. Physiol Behav 2009; 97: 537–550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Raynor HA, Vadiveloo M. Understanding the relationship between food variety, food intake, and energy balance. Curr Obes Rep 2018; 7: 68–75. [DOI] [PubMed] [Google Scholar]
- 33.Nguyen BP, Powell LM. The impact of restaurant consumption among US adults: Effects on energy and nutrient intakes. Public Health Nutr 2014; 17: 2445–2452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Harris JL, Bargh JA, Brownell KD. Priming effects of television food advertising on eating behavior. Health Psychol 2009; 28: 404–413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Dongen MV-V, Kok FJ, de Graaf C. Eating rate of commonly consumed foods promotes food and energy intake. Appetite 2011; 56: 25–31. [DOI] [PubMed] [Google Scholar]
- 36.Vercammen KA, Frelier JM, Moran AJ, Dunn CG, Musicus AA, Wolfson J, Ullah OS, Bleich SN. Understanding price incentives to upsize combination meals at large US fast-food restaurants. Public Health Nutr 2020; 23: 348–355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rolls BJ, Roe LS, Kral TV, Meengs JS, Wall ED. Increasing the portion size of a packaged snack increases energy intake in men and women. Appetite 2004; 42: 63–69. [DOI] [PubMed] [Google Scholar]
- 38.Wansink B, Kim J. Bad popcorn in big buckets: portion size can influence intake as much as taste. J Nutr Educ Behav 2005; 37: 242–245. [DOI] [PubMed] [Google Scholar]
- 39.Gill S, Panda S. A smartphone app reveals erratic diurnal eating patterns in humans that can be modulated for health benefits. Cell Metab 2015; 22: 789–798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Popp CJ, Curran MN, Wang C, Prassad M, Fine K, Gee A, Nair N, Perdomo K, Chen S, Hu L, St-Jules DE, Manoogian ENC, Panda S, Sevick MA, Laferrere. Temporal eating patterns and eating windows among adults with overweight or obesity. Nutrients 2021; 13: 4485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Vandevijvere S, Chow CC, Hall KD, Umali E, Swinburn BA. Increased food energy supply as a major driver of the obesity epidemic: A global analysis. Bull World Health Organ 2015; 93: 446–456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zobel EH, Hansen T, Rossing P, von Scholten BJ. Global Changes in Food Supply and the Obesity Epidemic. Curr Obes Rep 2016; 5: 449–455. [DOI] [PubMed] [Google Scholar]
- 43.Smoliga JM. Modelling the maximal active consumption rate and its plasticity in humans-perspective from hot-dog eating competition. Biol Lett 2020; 16: 20200096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.US Department of Agriculture and US Department of Health and Human Services Dietary Guidelines for Americans, 2010 7th Edition. Washington, DC: U.S. Government Printing Office; 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Keys A, Grande F. Role of dietary fat in human nutrition:Ill Diet and the epidemiology of coronary heart disease. Am J Public Health N ations Health 1957, 47, 1520–1530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Cohen E, Cragg M, deFonseka J, Hite A, Rosenberg M, Zhou B. Statistical review of US macronutrient consumption data, 1965±2011: Americans have been following dietary guidelines, coincident with the rise in obesity. Nutrition 2015; 31 :727–732. [DOI] [PubMed] [Google Scholar]
- 47.Gluck ME, Venti CA, Arline D, Salbe AD, Votruba SB, Jonathan Krakoff J. Higher 24-h respiratory quotient and higher spontaneous physical activity in nighttime eaters. Obesity (Silver Spring) 2011. ; 19:319–323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Stahl ML, Orr WC, Bollinger C. Postprandial documentation sleepiness: objective via polysomnography. Sleep 1983; 6: 29–35. [DOI] [PubMed] [Google Scholar]
- 49.Rautenberg A, Kuznesof AW, Self-starvation of rats living in activity wheels on a restricted feeding schedule. J Comp Physiol Psychol 1967; 64: 414–421. [DOI] [PubMed] [Google Scholar]
- 50.Rising R, Harper IT, Fintvielle AM, Ferraro RT, SprauI M, Ravussin E. Determinants of total daily energy expenditure: Variability in physical activity. Am J Clin Nutr 1994; 59: 800–804. [DOI] [PubMed] [Google Scholar]
- 51.Schulz L, Schoeller DA. A compilation of total daily energy expenditures and body weights in healthy adults. Am J Clin Nutr 1994; 60: 676–681 . [DOI] [PubMed] [Google Scholar]
- 52.Bassett DR, Schneider PL, Huntington GE. Physical activity in an Old Order Amish community. Med Sci Sports Exerc 2004; 36: 79–85. [DOI] [PubMed] [Google Scholar]
- 53.Bell AC, Ge K, Popkin BM. the road to obesity or the path to prevention: motorized transportation and obesity in China. Obes Res 2002; 10: 277–283. [DOI] [PubMed] [Google Scholar]
- 54.Swanson KC, Cormack GR. The relations between driving behavior, physical activity, and weight status among Canadian adults. J Phys Act Health 2012; 9: 352–359. [DOI] [PubMed] [Google Scholar]
- 55.Frank LD, Andresen M, Schmid TL. Obesity relationships with community design, physical activity, and time spent in cars. Am J Prev Med 2004; 27: 87–96. [DOI] [PubMed] [Google Scholar]
- 56.Lindstrom M Means of transportation to work and overweight and obesity: A population-based study in southern Sweden. Prev. Med 2008; 46: 22–28. [DOI] [PubMed] [Google Scholar]
- 57.Heldstab SA, van Schaik CP, Isler K. Being fat and smart: A comparative analysis of the fat-brain trade-off in mammals. J Hum Evol 2016; 100: 25–34. [DOI] [PubMed] [Google Scholar]
- 58.Wells JCK. The evolution of human fatness and susceptibility to obesity: An ethological approach. Biol Rev 2006; 81: 183–205. [DOI] [PubMed] [Google Scholar]
- 59.Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404:661–671 . [DOI] [PubMed] [Google Scholar]
- 60.Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372(6505): 425–432. [DOI] [PubMed] [Google Scholar]
- 61.Frederich RC, Hamann A, Anderson S, Lollman B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Med 1995; 1: 1311–1314. [DOI] [PubMed] [Google Scholar]
- 62.Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial. JAMA 1999; 282: 1568–1575. [DOI] [PubMed] [Google Scholar]
- 63.Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, Gallagher D, Mayer L, Murphy E, Leibel RL. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 2005; 115: 3579–3586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Sobhani I, Bado A, Vissuzaine C, Buyse M, Kermorgant S, Laigneau JP, Attoub S, Lehy T, Henin D, Mignon M, Lewin MJ. Leptin secretion and leptin receptor in the human stomach. Gut 2000; 47: 178–183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Cammisotto PG, Levy E, Bukowiecki LJ , Bendayan M. Cross-talk between adipose and gastric leptins for the control of food intake and energy metabolism. Prog Histochem Cytochem 2010; 45: 143–200. [DOI] [PubMed] [Google Scholar]
- 66.Borer KT. Counterregulation of insulin by leptin as key component of autonomic regulation of body weight. World J Diabetes 2014; 5: 606–629 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Farooqi S; Keogh JM; Karnath S; Jones S; Gibson W; Trussell R; Jebb SA; Lip GYH; O’Rahilly S Partial leptin deficiency and human adiposity. Nature 2001; 414: 34–35. [DOI] [PubMed] [Google Scholar]
- 68.Friedman JM. Leptin and the endocrine control of energy balance. Nat Metab 2019; 1: 754–764. [DOI] [PubMed] [Google Scholar]
- 69.Geliebter A Gastric distension and gastric capacity in relation to food intake in humans. Physiol Behav 1988; 44: 665–668. [DOI] [PubMed] [Google Scholar]
- 70.Geliebter A, Melton PM, McCray RS, Gallagher DR, Gage D, Hashim SA. Gastric capacity, gastric emptying, and test-meal intake in normal and bulimic women. Am J Clin Nutr 1992; 56: 656–661. [DOI] [PubMed] [Google Scholar]
- 71.Geliebter A, Scha chter S, Lohmann-Walter C, Feldman H, Hashim SA. Reduced stomach capacity in obese subjects after dieting. Am J Clin Nutr 1996; 63: 170–173. [DOI] [PubMed] [Google Scholar]
- 72.Stewart WK, Fleming LW. Features of a successful therapeutic fast of 382 days duration. Postgrad Med J 1973; 49: 203–209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Borer KT. Why we eat too much, have an easier time gaining than losing weight, and expend too little energy: Suggestions for counteracting or mitigating these problems. Nutrients 2021; 13: 3812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Buettner D, Skemp S. Blue zones: Lessons from the world’s longest lived. Am J Lifestyle Med 2016; 10: 318–321 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Pacanowski CR, Bertz F, Levitsky DA. Daily self-weighing to control body weight in adults: A critical review of the literature. SAGE Open 2014; 4: 1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Manoogian ENC, Chow LS, Taub PR, Laferrere B, Panda S. Time-restricted eating for the prevention and management of metabolic diseases. Endocr Rev 2022; 43: 405–436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Stekovic S, Hofer SJ, Tripolt N, Aon MA, Royer P, Pein L, Stadler JT, Pendl T, Prietl B, Uri J, Schroeder S, Tadic J, Eisenberg T, Magnes C, Stumpe M, Zuegner E, Bordag N, Riedl R, Schmidt A, Kolesnik E, Verheyen N, Springer A, Madi T, Sinner F, de Cabo R, Kroemer G, Obermayer-Pietsch B, Dengjel J, Sourij H, Pieber TR, Madeo F. Alternate-day fasting improves physiological and molecular markers of aging in healthy, non-obese humans. Cell Metab 2019; 30: 462–476. [DOI] [PubMed] [Google Scholar]
- 78.Borer KT, Sirk M, Wuorinen E. Health benefits of weight-loss and metabolic switching compared in nine different intermittent fasting protocols. Nutrients 2023. (under review). [Google Scholar]
